查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945357

2026年全球植入式神经刺激设备市场报告

Implantable Neurostimulation Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，植入式神经刺激设备市场发展迅速，预计将从2025年的56.2亿美元成长到2026年的62.7亿美元，复合年增长率达11.7%。过去几年的成长可归因于神经系统疾病盛行率的上升、疼痛管理治疗的扩展、植入式刺激技术的应用、神经调控疗法在临床上的日益普及以及植入式电子系统的广泛使用。

预计未来几年植入式神经刺激设备市场将快速成长，到2030年市场规模将达到100.2亿美元，复合年增长率（CAGR）为12.4%。预测期内的成长要素包括：对非药物疗法的需求不断增长、对精准神经调控的日益重视、门诊神经治疗的扩展、脑机介面研究投入的增加以及刺激演算法的不断创新。预测期内的主要趋势包括：先进神经刺激疗法的普及率不断提高、可充电刺激器的广泛应用、个性化神经调控疗法的日益普及、多适应症神经刺激系统的扩展以及对长期治疗效果的日益关注。

预计未来几年，神经系统疾病盛行率的不断上升将推动植入式神经刺激设备市场的成长。神经系统疾病是指影响神经系统结构和功能的疾病，会导致瘫痪、癫痫发作和认知障碍等症状。高血压、发育异常、创伤和损伤等风险因素的增加是导致这些疾病盛行率上升的原因之一。当传统治疗方法无效或效果不佳时，植入式神经刺激设备可用于调节神经活动并缓解症状。例如，根据美国非营利组织阿兹海默症协会统计，截至2024年，约有690万65岁及以上的美国人患有阿兹海默症，其中73%的患者年龄在75岁及以上。预计到2050年，这数字将达到1,270万。因此，神经系统疾病盛行率的不断上升预计将推动对植入式神经刺激设备的需求。

植入式神经刺激设备市场的公司正致力于开发先进系统，例如可充电式脑电感测神经刺激设备，旨在为运动障碍和神经系统疾病患者提供更个人化和适应性的治疗方案。这些设备植入体内后，可在提供标靶刺激的同时记录即时脑波讯号，使临床医生能够根据个别神经活动和长期治疗需求来微调治疗方案。例如，2024年1月，美国医疗设备製造商Medtronic）的Percept RC神经刺激设备获得了美国食品药物管理局（FDA）的核准。 Percept RC是一款可充电式深部脑部刺激（DBS）系统，采用美敦力专有的BrainSense技术。该设备能够捕获并追踪脑波讯号，从而优化个人化治疗。凭藉至少15年的使用寿命、灵活的定向刺激编程和快速充电功能，该设备为运动障碍患者提供了持久耐用且可自订的治疗选择。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球植入式神经刺激设备市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 先进神经刺激疗法的应用日益广泛
    • 可充电式刺激器的使用率不断提高
    • 扩大个人化神经调控疗法的应用
    • 扩展多适应症神经刺激系统
    • 人们越来越关注长期治疗效果

第五章 终端用户产业市场分析

  • 医院
  • 神经科诊所
  • 疼痛管理中心
  • 门诊手术中心
  • 復健中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球植入式神经刺激设备市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球植入式神经刺激设备市场规模、对比及成长率分析
  • 全球植入式神经刺激设备市场表现：规模与成长，2020-2025年
  • 全球植入式神经刺激设备市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 脊髓刺激（SCS）、胃电刺激（GES）、深部脑部刺激（DBS）、荐椎神经刺激（SNS）、迷走神经刺激（VNS）、其他类型
  • 透过使用
  • 疼痛管理、帕金森氏症、尿失禁和粪便失禁、癫痫、胃轻瘫及其他适应症
  • 最终用户
  • 医院、诊所及门诊手术中心
  • 按类型细分：脊髓刺激（SCS）
  • 可充电式SCS设备，不可充电式SCS设备
  • 按类型细分：胃电刺激（GES）
  • 植入式胃刺激器，可调式胃刺激器
  • 按类型细分：深部脑部刺激（DBS）
  • 用于治疗运动障碍的深部脑部刺激（DBS）装置，用于治疗精神疾病的深部脑部刺激（DBS）装置
  • 按类型细分：荐椎神经刺激（SNS）
  • 用于治疗尿失禁的荐神经刺激装置，用于治疗粪便失禁的荐神经刺激装置
  • 按类型细分：迷走神经刺激（VNS）
  • 用于治疗癫痫的迷走神经刺激装置，用于治疗忧郁症的迷走神经刺激装置
  • 按类型细分：其他类型
  • 週边神经刺激（PNS）、皮质刺激装置、新型神经刺激技术

第十章 区域与国家分析

  • 全球植入式神经刺激设备市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球植入式神经刺激设备市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 植入式神经刺激设备市场：竞争格局与市场占有率（2024 年）
  • 植入式神经刺激设备市场：公司估值矩阵
  • 植入式神经刺激设备市场：公司概况
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • St. Jude Medical LLC
    • LivaNova PLC

第37章：其他领先和创新企业

  • Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Curonix LLC, Inspire Medical Systems Inc., SetPoint Medical Corporation, ElectroCore Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年植入式神经刺激设备市场：提供新机会的国家
  • 2030年植入式神经刺激设备市场：充满新机会的细分市场
  • 2030年植入式神经刺激设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4TINDE02_G26Q1

Implantable neurostimulation devices are medical devices designed to deliver electrical stimulation to specific areas of the nervous system to treat various neurological and psychological conditions. These devices are surgically implanted into the body to modulate nerve activity, offering a sophisticated approach for managing conditions that may not respond adequately to medication alone, thereby enhancing patients' quality of life.

The primary types of implantable neurostimulation devices include spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and others. Spinal cord stimulation (SCS) therapy uses mild electrical currents to block pain signals from reaching the brain, providing effective management for chronic pain conditions. These devices are applied in treating pain management, Parkinson's disease, urinary and fecal incontinence, epilepsy, gastroparesis, and other conditions. They are used by various end-users, including hospitals, clinics, and ambulatory surgical centers.

Tariffs are impacting the implantable neurostimulation devices market by increasing costs of imported microelectronics, electrodes, batteries, sensors, and software-enabled control units. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported advanced components, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are increasing therapy system prices and slowing adoption in cost-sensitive healthcare systems. However, they are also driving local manufacturing, regional R&D investment, and development of cost-efficient neurostimulation platforms.

The implantable neurostimulation devices market research report is one of a series of new reports from The Business Research Company that provides implantable neurostimulation devices market statistics, including implantable neurostimulation devices industry global market size, regional shares, competitors with a implantable neurostimulation devices market share, detailed implantable neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable neurostimulation devices industry. This implantable neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable neurostimulation devices market size has grown rapidly in recent years. It will grow from $5.62 billion in 2025 to $6.27 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rising prevalence of neurological disorders, expansion of pain management treatments, adoption of implantable stimulation technologies, increasing clinical acceptance of neuromodulation, availability of implantable electronic systems.

The implantable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $10.02 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing demand for non-pharmacological therapies, rising focus on precision neuromodulation, expansion of outpatient neurological treatments, growing investment in brain-machine interface research, increasing innovation in stimulation algorithms. Major trends in the forecast period include increasing deployment of advanced neurostimulation therapies, rising adoption of rechargeable stimulation devices, growing use of personalized neuromodulation treatments, expansion of multi-indication neurostimulation systems, enhanced focus on long-term therapy effectiveness.

The increasing prevalence of neurological disorders is expected to drive the growth of the implantable neurostimulation devices market in the coming years. Neurological disorders are conditions that affect the structure or function of the nervous system, resulting in symptoms such as paralysis, seizures, and cognitive impairments. Greater exposure to risk factors such as high blood pressure, developmental abnormalities, trauma, or injury contributes to higher detection rates of these disorders. Implantable neurostimulation devices are used to modulate nerve activity and alleviate symptoms when conventional treatments are ineffective or insufficient. For example, according to the Alzheimer's Association, a US-based non-profit organization, an estimated 6.9 million Americans aged 65 and older were living with Alzheimer's disease in 2024, with 73% being 75 years or older. This number is projected to reach 12.7 million by 2050. Thus, the rising prevalence of neurological disorders is expected to fuel the demand for implantable neurostimulation devices.

Companies in the implantable neurostimulation devices market are focusing on developing advanced systems, such as rechargeable brain-sensing neurostimulators, to provide more personalized and adaptive therapy for patients with movement and neurological disorders. These devices are implanted to record real-time brain signals while delivering targeted stimulation, allowing clinicians to fine-tune therapy based on individual neural activity and long-term treatment requirements. For instance, in January 2024, Medtronic, a US-based medical device company, received U.S. Food and Drug Administration (FDA) approval for its Percept RC neurostimulator, a rechargeable deep brain stimulation (DBS) system featuring exclusive BrainSense technology. The device captures and tracks brain signals to optimize personalized therapy. It offers a service life of at least 15 years, flexible directional stimulation programming, and rapid recharging capabilities, providing patients with a durable and customizable option for managing movement disorders.

In September 2023, Amber Therapeutics, a UK-based provider of neuromodulation therapies, acquired Bioinduction for an undisclosed amount. This acquisition strengthens Amber's strategic capabilities by incorporating Bioinduction's implantable-device hardware, engineering expertise, and manufacturing know-how to support next-generation neuromodulation solutions. It also accelerates the development and commercialization of Amber-UI by integrating proven implantable neurostimulation technology into Amber's platform. Bioinduction is a UK-based manufacturer of implantable neurostimulation devices.

Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Curonix LLC, Inspire Medical Systems Inc., SetPoint Medical Corporation, ElectroCore Inc.

North America was the largest region in the implantable neurostimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable neurostimulation devices market consists of sales of responsive neurostimulation systems, peripheral nerve stimulation systems, cerebral spinal fluid shunt systems and electroceutical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Neurostimulation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses implantable neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Spinal Cord Stimulation (SCS); Gastric Electric Stimulation (GES); Deep Brain Stimulation (DBS); Sacral Nerve Stimulation (SNS); Vagus Nerve Stimulation (VNS); Other Types
  • 2) By Application: Pain Management; Parkinson's Disease; Urinary And Fecal Incontinence; Epilepsy; Gastroparesis; Other Applications
  • 3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices; Non-Rechargeable SCS Devices
  • 2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators; Adjustable Gastric Stimulators
  • 3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders; DBS Devices for Psychiatric Disorders
  • 4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence; SNS Devices for Fecal Incontinence
  • 5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy; VNS Devices for Depression
  • 6) By Other Types: Peripheral Nerve Stimulation (PNS); Cortical Stimulation Devices; Novel Neurostimulation Technologies
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; St. Jude Medical LLC; LivaNova PLC; Nevro Corp.; Axonics Inc.; NeuroPace Inc.; Bioness Inc.; Saluda Medical Pty Ltd.; SceneRay Co. Ltd.; NeuroMetrix Inc.; Synapse Biomedical Inc.; NeuroSigma Inc.; Nuvectra Corporation; MicroTransponder Inc.; Curonix LLC; Inspire Medical Systems Inc.; SetPoint Medical Corporation; ElectroCore Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Implantable Neurostimulation Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Implantable Neurostimulation Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Implantable Neurostimulation Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Implantable Neurostimulation Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Deployment Of Advanced Neurostimulation Therapies
    • 4.2.2 Rising Adoption Of Rechargeable Stimulation Devices
    • 4.2.3 Growing Use Of Personalized Neuromodulation Treatments
    • 4.2.4 Expansion Of Multi-Indication Neurostimulation Systems
    • 4.2.5 Enhanced Focus On Long-Term Therapy Effectiveness

5. Implantable Neurostimulation Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Neurology Clinics
  • 5.3 Pain Management Centers
  • 5.4 Ambulatory Surgical Centers
  • 5.5 Rehabilitation Centers

6. Implantable Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Implantable Neurostimulation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Implantable Neurostimulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Implantable Neurostimulation Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Implantable Neurostimulation Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Implantable Neurostimulation Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Implantable Neurostimulation Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Implantable Neurostimulation Devices Market Segmentation

  • 9.1. Global Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types
  • 9.2. Global Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pain Management, Parkinson's Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications
  • 9.3. Global Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Ambulatory Surgical Centers
  • 9.4. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulation (SCS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Rechargeable SCS Devices, Non-Rechargeable SCS Devices
  • 9.5. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Gastric Electric Stimulation (GES), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Gastric Stimulators, Adjustable Gastric Stimulators
  • 9.6. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Deep Brain Stimulation (DBS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders
  • 9.7. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Sacral Nerve Stimulation (SNS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence
  • 9.8. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Vagus Nerve Stimulation (VNS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • VNS Devices for Epilepsy, VNS Devices for Depression
  • 9.9. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies

10. Implantable Neurostimulation Devices Market Regional And Country Analysis

  • 10.1. Global Implantable Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Implantable Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Implantable Neurostimulation Devices Market

  • 11.1. Asia-Pacific Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Implantable Neurostimulation Devices Market

  • 12.1. China Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Implantable Neurostimulation Devices Market

  • 13.1. India Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Implantable Neurostimulation Devices Market

  • 14.1. Japan Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Implantable Neurostimulation Devices Market

  • 15.1. Australia Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Implantable Neurostimulation Devices Market

  • 16.1. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Implantable Neurostimulation Devices Market

  • 17.1. South Korea Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Implantable Neurostimulation Devices Market

  • 18.1. Taiwan Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Implantable Neurostimulation Devices Market

  • 19.1. South East Asia Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Implantable Neurostimulation Devices Market

  • 20.1. Western Europe Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Implantable Neurostimulation Devices Market

  • 21.1. UK Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Implantable Neurostimulation Devices Market

  • 22.1. Germany Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Implantable Neurostimulation Devices Market

  • 23.1. France Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Implantable Neurostimulation Devices Market

  • 24.1. Italy Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Implantable Neurostimulation Devices Market

  • 25.1. Spain Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Implantable Neurostimulation Devices Market

  • 26.1. Eastern Europe Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Implantable Neurostimulation Devices Market

  • 27.1. Russia Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Implantable Neurostimulation Devices Market

  • 28.1. North America Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Implantable Neurostimulation Devices Market

  • 29.1. USA Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Implantable Neurostimulation Devices Market

  • 30.1. Canada Implantable Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Implantable Neurostimulation Devices Market

  • 31.1. South America Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Implantable Neurostimulation Devices Market

  • 32.1. Brazil Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Implantable Neurostimulation Devices Market

  • 33.1. Middle East Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Implantable Neurostimulation Devices Market

  • 34.1. Africa Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Implantable Neurostimulation Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Implantable Neurostimulation Devices Market Regulatory and Investment Landscape

36. Implantable Neurostimulation Devices Market Competitive Landscape And Company Profiles

  • 36.1. Implantable Neurostimulation Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Implantable Neurostimulation Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Implantable Neurostimulation Devices Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. St. Jude Medical LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

37. Implantable Neurostimulation Devices Market Other Major And Innovative Companies

  • Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Curonix LLC, Inspire Medical Systems Inc., SetPoint Medical Corporation, ElectroCore Inc.

38. Global Implantable Neurostimulation Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Implantable Neurostimulation Devices Market

40. Implantable Neurostimulation Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Implantable Neurostimulation Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Implantable Neurostimulation Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Implantable Neurostimulation Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer